USGIU
LUMO

U.S. Global Investors (USGI)’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

U.S. Global Investors (USGI)’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,333
Closed -$430K – 324
2015
Q3 		$430K Hold
1,333
– – 0.23% 104
2015
Q2 		$531K Buy
+1,333
New +$566K 0.2% 112

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

U.S. Global Investors (USGI)'s LUMO Position: Q4 2015 in Review

U.S. Global Investors (USGI) sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2015, closing a stake of 1,333 shares — an estimated $430K sold.

U.S. Global Investors (USGI) first reported a position in LUMO in Q2 2015 and held it in 2 quarters. The position peaked at $531K in Q2 2015. 152 funds tracked by Wall St. Rank hold LUMO as of Q4 2015.

  • U.S. Global Investors (USGI) reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • U.S. Global Investors (USGI) sold 1,333 Lumos Pharma, Inc. Common Stock shares in Q4 2015, an estimated $430K.
  • U.S. Global Investors (USGI) first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2015 and held it in 2 quarters.
  • U.S. Global Investors (USGI)'s Lumos Pharma, Inc. Common Stock position peaked at $531K in Q2 2015.
  • 152 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2015.

Based on U.S. Global Investors (USGI)'s 13F filing for Q4 2015, filed 16 Feb 2016.